Cart
sales@molnova.com
Chlorophos
CAS No. 52-68-6
Chlorophos( Metrifonate | Trichlorfon )
Catalog No. M19522 CAS No. 52-68-6
Metrifonate (INN) or trichlorfon (USAN) is an irreversible organophosphate acetylcholinesterase inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameChlorophos
-
NoteResearch use only, not for human use.
-
Brief DescriptionMetrifonate (INN) or trichlorfon (USAN) is an irreversible organophosphate acetylcholinesterase inhibitor.
-
DescriptionMetrifonate (INN) or trichlorfon (USAN) is an irreversible organophosphate acetylcholinesterase inhibitor. It is a prodrug which is activated non-enzymatically into 22-dichlorovinyl dimethyl phosphate (DDVP).
-
In Vitro——
-
In Vivo——
-
SynonymsMetrifonate | Trichlorfon
-
PathwayOthers
-
TargetOther Targets
-
RecptorChE
-
Research AreaOthers
-
IndicationPesticide; Vet Drug
Chemical Information
-
CAS Number52-68-6
-
Formula Weight257.44
-
Molecular FormulaC4H8Cl3O4P
-
Purity>98% (HPLC)
-
SolubilityH2O:30 mg/mL (116.53 mM)
-
SMILESCOP(=O)(OC)C(O)C(Cl)(Cl)Cl
-
Chemical NameDimethyl(222-trichloro-1-hydroxyethyl)phosphonate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Mele T Juri? DM.Pharmacol Rep. 2014 Aug;66(4):618-23.
molnova catalog
related products
-
N6F11
N6F11 is a novel, selective and potent inducer of ferroptosis with anticancer and antitumour activity that promotes GPX4 degradation by binding to TRIM25 in cancer cells.
-
YAP-TEAD-IN-3
YAP-TEAD-IN-3 is an inhibitor of YAP/TAZ-TEAD interactions with an IC50 of 9 nM for Avi-human TEAD (4217-434).
-
Acoramidis hydrochlo...
Acoramidis hydrochloride (Alxn2060 hydrochloride) is an orally active and selective kinetic stabilizer of WT and V122I- TTR (transthyretin) . Acoramidis hydrochloride is used in the study for transthyretin amyloidosis.
